Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Edit custom filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
2003 4
2004 4
2005 2
2006 6
2007 7
2008 14
2009 5
2010 16
2011 12
2012 18
2013 14
2014 12
2015 13
2016 13
2017 13
2018 20
2019 7
2020 10
2021 9
2022 10
2023 8
2024 7
2025 5
2026 2

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

212 results

Results by year

Filters applied: . Clear all
Page 1
Oncolytic virotherapy.
Russell SJ, Peng KW, Bell JC. Russell SJ, et al. Among authors: bell jc. Nat Biotechnol. 2012 Jul 10;30(7):658-70. doi: 10.1038/nbt.2287. Nat Biotechnol. 2012. PMID: 22781695 Free PMC article. Review.
Introduction to Oncolytic Virotherapy.
Engeland CE, Bell JC. Engeland CE, et al. Among authors: bell jc. Methods Mol Biol. 2020;2058:1-6. doi: 10.1007/978-1-4939-9794-7_1. Methods Mol Biol. 2020. PMID: 31486028 Review.
Contribution of NK cells to immunotherapy mediated by PD-1/PD-L1 blockade.
Hsu J, Hodgins JJ, Marathe M, Nicolai CJ, Bourgeois-Daigneault MC, Trevino TN, Azimi CS, Scheer AK, Randolph HE, Thompson TW, Zhang L, Iannello A, Mathur N, Jardine KE, Kirn GA, Bell JC, McBurney MW, Raulet DH, Ardolino M. Hsu J, et al. Among authors: bell jc. J Clin Invest. 2018 Oct 1;128(10):4654-4668. doi: 10.1172/JCI99317. Epub 2018 Sep 10. J Clin Invest. 2018. PMID: 30198904 Free PMC article.
Complementary dual-virus strategy drives synthetic target and cognate T-cell engager expression for endogenous-antigen agnostic immunotherapy.
Taha Z, Crupi MJF, Alluqmani N, MacKenzie D, Vallati S, Whelan JT, Fareez F, Alwithenani A, Petryk J, Chen A, Spinelli MM, Ng K, Sobh J, de Souza CT, Bharadwa PR, Lee TKH, Thomas DA, Huang BZ, Kassas O, Poutou J, Gilchrist VH, Boulton S, Thomson M, Marius R, Hooshyar M, McComb S, Arulanandam R, Ilkow CS, Bell JC, Diallo JS. Taha Z, et al. Nat Commun. 2024 Aug 23;15(1):7267. doi: 10.1038/s41467-024-51498-0. Nat Commun. 2024. PMID: 39179564 Free PMC article.
Advances in oncolytic virotherapy.
Russell SJ, Bell JC, Engeland CE, McFadden G. Russell SJ, et al. Among authors: bell jc. Commun Med (Lond). 2022 Apr 7;2:33. doi: 10.1038/s43856-022-00098-4. eCollection 2022. Commun Med (Lond). 2022. PMID: 35603308 Free PMC article.
Antibiotic-mediated selection of randomly mutagenized and cytokine-expressing oncolytic viruses.
Rezaei R, Boulton S, Ahmadi M, Petryk J, Da Silva M, Kooshki Zamani N, Singaravelu R, St-Laurent G, Daniel L, Sadeghipour A, Pelin A, Poutou J, Munoz Zuniga AI, Choy C, Gilchrist VH, Khalid Z, Austin B, Onsu KA, Marius R, Ameli Z, Mohammadi F, Mancinelli V, Wang E, Nik-Akhtar A, Alwithenani A, Panahi Arasi F, Ferguson SSG, Hobman TC, Alain T, Tai LH, Ilkow CS, Diallo JS, Bell JC, Azad T. Rezaei R, et al. Among authors: bell jc. Nat Biomed Eng. 2025 Jun;9(6):822-835. doi: 10.1038/s41551-024-01259-7. Epub 2024 Nov 28. Nat Biomed Eng. 2025. PMID: 39609558
Oncolytic viruses-immunotherapeutics on the rise.
Keller BA, Bell JC. Keller BA, et al. Among authors: bell jc. J Mol Med (Berl). 2016 Sep;94(9):979-91. doi: 10.1007/s00109-016-1453-9. Epub 2016 Aug 4. J Mol Med (Berl). 2016. PMID: 27492706 Review.
Going viral with cancer immunotherapy.
Lichty BD, Breitbach CJ, Stojdl DF, Bell JC. Lichty BD, et al. Among authors: bell jc. Nat Rev Cancer. 2014 Aug;14(8):559-67. doi: 10.1038/nrc3770. Epub 2014 Jul 3. Nat Rev Cancer. 2014. PMID: 24990523 Review.
212 results